Clinician-investigator (CI) training has become an area of focus in Canada due to the urgent need for a greater number of medical professionals carrying out patient-oriented research in a wide array of medical elds [1] . At present, 15 of the 17 medical schools in Canada o er one or more programs that combine medical and graduate research training [1, 2] . ese programs include Clinician Investigator Programs (CIP) (accredited by the Royal College of Physicians and Surgeons of Canada) in which graduate training is obtained during residency, as well as MD/PhD and MD/MSc programs in which graduate training occurs during undergraduate MD education. Although curriculum structure varies between program type and institution, their collective purpose is to provide graduate level research training for medical students and residents.
Evaluation of demographics and funding were key need areas identi ed by a Canadian study, which recommended improving the clinician-scientist pathway to stimulate the dwindling number of physicians who incorporate research into their careers [3] . Demographic data represent critical information to several key stakeholders and may lead to changes in the number of students aware of (or applying to) each program, increase funding available to trainees, and assist in program and curriculum self-evaluation and accreditation. Unfortunately, gaps in reporting have resulted in a poor understanding of Canadian CI training demographics.
e Clinician Investigator Trainee Association of Canada (CITAC) is a Canadian not-for-pro t organization exclusively founded and operated by CI trainees and has a fundamental interest in studying Canadian CI training demographics. CI-TAC has launched an initiative to collect, analyze and disseminate information regarding the number and distribution of CI trainees in Canadian programs. is initial report aims to provide analysis of basic demographic and funding information to facilitate evaluation of CI training in Canada.
Methods
CITAC census survey questions were designed to capture demographic data points from each type of CI training program (CIP, MD/PhD and MD/MSc). First, an exhaustive search to identify all CI training programs across Canada was undertaken. Initially, online research at each institution o ering training in medicine was completed using publicly available search engines, institutional search engines and manual browsing of institution web sites to identify which institutions offered any of the three CI training programs above. If no program was identi ed through online research, telephone calls were made to each medical school undergraduate and postgraduate education o ces to inquire of the existence of such a program. e search also undertook to obtain the current contact information of the program o ces and directors for each identi ed program. e ndings were cross-referenced with program directors at other institutions to ensure the accuracy of the search and that no program had been overlooked.
Next, the survey was developed by the authors and in consultation with an expert panel including program directors at three di erent CI training programs (one of each description above). e survey was distributed via email directly to both program directors and program administrators for each CI training program, inviting them to participate and requesting con rmation of their participation. All responses were followed up by either a telephone call or email to the program director's o ce (either program director or administrative assistant). Follow up communications inquired of the methods by which each program tracks their trainee demographic data. Each program con rmed that they had actively tracked and documented all demographic parameters requested in the survey at least for the current academic year (in this case 2010-2011), if not on an ongoing/historical basis. Responses included the completed survey completed by either the program director or program administrator -although the latter required the approval of program director for participation and veri cation of data quality. Every institution o ering one or more CI training programs agreed to participate and submitted their demographic data for the 2010-2011 academic year.
e current (2010-2011) data therefore represents a complete census (100% institution and program participation) of CI training in Canada.
Notably, census data includes all "enrolled" trainees at the point in time data were collected. Enrollment included all trainees in either research or clinical training phases of their respective CI training program. In addition to enrolment, additional data collected included the number of applicants that applied to each program for the 2010-2011 cycle, withdrawals and graduations from each program and gender distribution. No personal identifying data was collected at any point in the study.
Historical enrolment data was purchased by CITAC from the Association of Faculties of Medicine of Canada (AFMC). Enrolment numbers since 1997-1998 for MD/PhD and MD/ MSc and since 1999-2000 for CIP programs are included for comparative analysis. AFMC data was collected through undergraduate and post-graduate medical training programs.
erefore, historical data provided by the AFMC may not include all CI trainees enrolled in the graduate/research phases of their programs; however, the number omitted is likely to be a small proportion. It nevertheless points to the need to collect CI trainees obtain funding from a wide variety of sources including provincial and national granting agencies, academic institutions, industry and specialized not-for-pro t associations. e diversity of funding opportunities challenges the collection of complete funding data. erefore, CITAC focused on MD/PhD-speci c funding opportunities. is included expenditures dating back to 1999 from the MRC/ CIHR MD/PhD studentship award program, the Scriver Family MD/PhD studentship program, and the current CIHR MD/PhD program grants (Fig. 1a) .
Results

Changes in CI Training Enrolment
In 2010-2011, 452 Canadian CI trainees were actively enrolled, including 209 in CIP, 170 in MD/PhD and 73 in MD/ MSc programs (Table 1) . It should be noted that this data does not include clinician investigator trainees who are not involved in a formal CI training program. When compared with historical data, funding and total enrolment have increased approximately 4-fold since the late 1990s (Fig. 1a , Table 1 
Distribution of Trainees Across Training Programs and Institutions
Signi cant variation in program size was observed across the 15 institutions ( Table 2 ). e University of Toronto has the largest CIP (111 trainees) and MD/PhD (43 trainees) programs in Canada, whereas enrolment in most programs ranges from 5-45 trainees. Enrolment was nearly equal in CIP and MD/PhD programs at six of the 10 institutions, suggesting there may be a complementary relationship between these two particular programs. Active MD/PhD programs are located at 13 institutions, CIP programs are active at 11 institutions and four institutions had active MD/MSc programs at the time of this study.
Trends in Applications, Enrolment and Graduation
Trends in applications, admissions and exits were surprisingly similar across the country. In total, 349 applications were made to CI training programs in 2010. e majority (~65%) of applications were to MD/PhD programs (Fig. 1b) . Of these, only 34 students (15% of MD/PhD applications) successfully obtained admission in 2010-2011. In contrast, the majority of applicants to CIP and MD/MSc programs were granted admission (91% and 86%, respectively). It should be acknowledged that MD/PhD applicants might submit applications to multiple programs to increase the odds of acceptance, more so than CIP and MD/MSc trainees who are already enrolled in residency or MD programs (respectively) at their institution. Our data does not contain information about individual applicants, so we were unable to correct for multiple applications per candidate. Our experience indicates that most applicants apply to 1-3 MD/PhD programs, despite applying to several more MD programs simultaneously. If so, acceptance to MD/ PhD programs would still be estimated at only 30%. Relatively low acceptance rates to the MD/PhD programs (vs. other CI training programs) may be attributed to di erences in the admissions process. Admission to MD/PhD programs tends to be in parallel or extramural to the admissions process for MD programs. is requires application to the MD/PhD stream prior to obtaining admission in the local MD program. In contrast, CIP and MD/MSc trainees are o en actively enrolled in a residency or MD program (respectively) at the time of application. ere is much discussion in the medical education community regarding the implications and outcomes of these distinct admissions processes, which is beyond the scope of this analysis. Nonetheless, these are important questions to address as the outcomes are potentially di erent [5] .
Sustainability and Attrition
It appears that applications to CI training programs are high enough to sustain the current size of each type of training program and, in the case of MD/PhD programs, stimulate further growth if warranted (Table 3) . Successful completion of the training program is perhaps an even more important indicator of progress toward training future clinician investigators. Unfortunately, historical data is not available to address this question; however, the CITAC census shows that 101 trainees exited Canadian CI training programs in 2010-2011 (Table 3) .
Of these, 76 successfully completed (graduated) the program and 25 (5.5% of enrolled trainees) withdrew without completing all degree requirements (17 CIP, seven MD/PhD and one MD/MSc; Table 3 ). While case-speci c reasons for withdrawing were not collected for reasons of privacy, irreconcilable differences with research personnel/supervisors, personal life crises, change in career goals and lack of funding were most-o en cited. Attrition has been experienced and addressed in part by various groups in the United States [6, 7] . ese studies suggested that career satisfaction as a clinical investigator is strongly in uenced by factors such as personal sacri ce and lack of job security.
Gender Disparity Among CI Trainees
Historically, enrolment in Canadian faculties of medicine has been predominantly male; however, female enrolment has steadily increased since 1968. In 2010-2011, female enrolment sits at nearly 58% of all medical trainees [8] . Interestingly, only 44% of Canadian CI trainees are female in 2010-2011, a trend which is particularly evident in CIP and MD/PhD programs (Table 3 ). In contrast, there is nearly a 2:1 female to male trainee ratio in MD/MSc programs. It may be reasoned that female trainees generally prefer to enroll in shorter CI training programs such as MD/MSc; however, CIP programs (58% male enrolment) almost always consist of Masters-length train- ing during residency. Alternative explanations, such as a shortage of female role models to encourage interest among female trainees, need to be explored.
CIHR MD/PhD Funding
Funding for CI training programs has been described as a major challenge for program directors regardless of program structure. Trainees are o en supported by a wide variety of funding opportunities, making it very di cult to track sources and degree of nancial support. e MD/PhD program is unique in that it does have dedicated funding from CIHR to partially support trainees. Expenditures from these dedicated programs over the 1999-2010 time period from CIHR (Fig. 1a) were compared with the total MD/PhD enrolment ( Figure 1b ): CIHR expenditures have steadily increased over this 11-year period and contributed heavily to the growth of Canadian MD/PhD programs. e current MD/PhD Program Grant is awarded to Program Directors and administered through each institution with exibility in allocating funds. Under this program, the maximum award per student is $22,000 annually for up to six years. Total annual expenditure was divided by $22,000 to approximate the number of "fully-funded" students in a given year. us, CIHR MD/PhD-dedicated funding resulted in 31% of trainees (34/111) in 2002, 75% of trainees (81/108) in 2007, and 52% of trainees (88/170) in 2010 being "fully funded". Most programs use this funding to provide scholarships to incoming trainees as a recruitment tool. It is important to note that many trainees must still apply for additional sources of funding (e.g. traditional CIHR PhD Studentships and other local and external opportunities) for support. Alternative sources of funding for MD/PhD students was not explored in this study, but likely account for substantial nancial support for students who are not funded through the CIHR MD/PhD dedicated funding programs. Furthermore, CIP programs and MD/MSc programs do not receive dedicated funding, which creates di culty in tracking and assessing the need for further nancial support. An in-depth investigation into nancial support for all CI trainees may be helpful in this regard.
Discussion
Training future clinical investigators is critical to linking scienti c and clinical research with clinical application. While there are several approaches to achieving this goal, formal CI training programs, including MD/MSc, MD/PhD and CIP programs, are well established and growing rapidly in Canada. erefore, studying the demographics of these programs is of interest to multiple stakeholders who will in uence or bene t from the activities of clinical investigators. It should be noted that one of the limitations of this study is that we relied entirely on reporting directly from the program o ces that administrate the CI training programs under study. Each program indicated they accurately track all demographic parameters requested in the survey. While we endeavoured to ensure that data collection was accurate, the possibility for errors or inconsistences in self-reporting is acknowledged and points toward the need for consistent and thorough tracking of Canadian CI trainees in all training program structures. A potential model for tracking of this information in MD/MSc and MD/PhD programs is exempli ed through the Royal College of Physicians and Surgeons of Canada, which not only accredits but also tracks enrolment and other demographics in Canadian CIP programs [9] . Tracking completion of thesis defense/equivalent research component (in addition to graduation from MD and graduate degree programs), as is currently the case for CIP programs, would be valuable to understanding the success of MD/PhD and MD/MSc programs in Canada as well.
Key issues identi ed in our study include the attrition of trainees prior to completion of the degree requirements for each program type. is issue is not new and has been experienced and addressed in part by various groups in the United States [6, 7] . e ndings of some of these studies suggest that the satisfaction of a career as a clinical investigator may be strongly outweighed by the factors such as personal sacri ce and lack of job security. While job security may be less of an issue in Canada, the strong need for more clinical investigators to be trained suggests that something should be done to address the shortage of enticing factors currently available to attract more physicians toward a career involving research. Included in these enticing factors is the availability of support throughout training programs; for example, we found that only 64% of MD/PhD trainees had complete funding from dedicated CIHR programs in 2010. It is possible that the expenses incurred in CI training programs may contribute to the attrition rate.
Gaps in Current Knowledge and Mo ing Forward
e rapid expansion of CI training over the past decade suggests strong interest in augmenting patient-oriented research in Canada. Over this same period, funding from CIHR for CI training programs has also increased, but recent plateaus in funding mean many trainees and programs still struggle for nancial support. Greater understanding of the diverse nature and extent of funding obtained by this high-needs, elite cohort is required. Funding for CIP programs historically has been quite variable, with less than 20% of funding coming from CIHR sources [10] . Taken together, it is reasonable to conclude that more robust funding for CI trainees and programs is needed and that need is increasing as enrolment grows. Importantly, nancial limitations may be a key component driving the high degree of attrition (5.5% of total enrollment in 2010). Further work to identify speci c reasons for withdrawal from CI programs should be completed. Moreover, attrition during training is only one obstacle reducing the number of clinician investigators reaching the 'market' . Although very di cult to study, tracking the activities of trainees a er completing their program is critically important to determine how many become actively engaged in patient-oriented research.
Conclusion
CITAC is well positioned as an association to begin to address some of these questions. is will require ongoing census taking and cooperation with CI programs and trainees. Continued monitoring of program demographics and analysis of trainee satisfaction will better inform sustainability of CI training programs, identify factors that impact successful completion of training, and may elucidate underlying reasons for gender disparity. e extent to which these di erences impact the career activities and pro les of the clinical investigators each type of program produces will likely not be clear for some time.
Once a larger number of graduates from these programs have entered the workforce, these results may be more easily obtained.
